Andlauer Healthcare Group Inc.
ANDHF
$37.71
-$2.99-7.35%
| Weiss Ratings | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.02 | |||
| Price History | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | -7.59% | |||
| 3-Year Total Return | 22.80% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $37.80 | |||
| 52-Week Low Price | $37.80 | |||
| 52-Week Low Price (Date) | Apr 19, 2024 | |||
| 52-Week High Price (Date) | Apr 19, 2024 | |||
| Valuation | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.26B | |||
| Enterprise Value | 1.31B | |||
| Price/Earnings (TTM) | 32.71 | |||
| Earnings Per Share (TTM) | 1.16 | |||
| Earnings Per Share Growth | -15.96% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.32 | |||
| Price/Book (Q) | 4.41 | |||
| Enterprise Value/Revenue (TTM) | 3.59 | |||
| Price | $37.80 | |||
| Enterprise Value/EBITDA (TTM) | 17.40 | |||
| Enterprise Value/EBIT | 24.26 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 42.18M | |||
| Dividend Yield | 0.70% | |||
| Div. Per Share (Most Recent) | $0.07 | |||
| Dividend Per Share (TTM) | $0.27 | |||
| Payout Ratio (TTM) | 21.48% | |||
| Dividend Per Share (Most Recent) | $0.07 | |||
| Company Info | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416-744-4900 | |||
| Address | 100 Vaughan Valley Boulevard Vaughan, ON L4H 3C5 | |||
| Website | andlauerhealthcare.com | |||
| Country | Canada | |||
| Year Founded | 1991 | |||
| Profitability | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 14.81% | |||
| Profit Margin | 10.20% | |||
| Management Effectiveness | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.53% | |||
| Return on Equity | 14.38% | |||
| Income Statement | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 480.10M | |||
| Total Revenue (TTM) | 480.10M | |||
| Revenue Per Share | $11.38 | |||
| Gross Profit (TTM) | 159.76M | |||
| EBITDA (TTM) | 99.17M | |||
| EBIT (TTM) | 71.14M | |||
| Net Income (TTM) | 48.99M | |||
| Net Income Avl. to Common (TTM) | 48.99M | |||
| Total Revenue Growth (Q YOY) | 1.75% | |||
| Earnings Growth (Q YOY) | -6.59% | |||
| EPS Diluted (TTM) | 1.16 | |||
| EPS Diluted Growth (Q YOY) | -6.53% | |||
| Balance Sheet | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 45.24M | |||
| Cash Per Share (Q) | $1.07 | |||
| Total Current Assets (Q) | 132.60M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 355.57M | |||
| Current Ratio (Q) | 2.520 | |||
| Book Value Per Share (Q) | $8.57 | |||
| Total Assets (Q) | 516.74M | |||
| Total Current Liabilities (Q) | 52.62M | |||
| Total Debt (Q) | 96.85M | |||
| Total Liabilities (Q) | 161.18M | |||
| Total Common Equity (Q) | 355.57M | |||
| Cash Flow | ANDHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -17.66M | |||
| Cash from Financing (TTM) | -63.91M | |||
| Net Change in Cash (TTM) | -4.53M | |||
| Levered Free Cash Flow (TTM) | 53.44M | |||
| Cash from Operations (TTM) | 77.40M | |||
